Life Sciences

Pharmaceutical, biotechnology, and medical device manufacturers are faced with unprecedented challenges in an increasingly complicated and uncertain environment.  Life sciences firms are finding it more difficult to maintain their historically strong growth rates as pricing pressures are causing profit margins to erode.  As a result, life sciences companies are compelled to demonstrate the value of their products, both to counter generic alternatives and to manage payer (e.g., government, private insurer, and consumer) pricing pressures.  Additionally, expensive and lengthy R&D cycles have created even greater pressure to deliver blockbuster products within shorter time periods.  Consequently, these firms are looking to extend the life cycle of their current products and identify new market opportunities within their product portfolio. 

Humedica’s novel clinical informatics solutions provide life sciences companies with the tools necessary to understand the clinical drivers of treatment decision-making, to quantify their brand’s unique benefits, and to accurately assess a myriad of market opportunities.


The Solution: Humedica’s Real-time Longitudinal Clinical Data
Humedica offers the timeliest and most complete clinical data needed to manage and succeed in today’s challenging marketplace. Our longitudinal clinical data offer unprecedented insight into brand choices and the associated clinical outcomes and cost effectiveness. With Humedica’s solutions, life sciences firms can more accurately and expediently quantify patient populations, market share, and market opportunities. We profile patient segments with detailed clinical specificity (e.g., lab results, radiology, co-morbidities), identify the clinical drivers of treatment decisions by physician specialty, and elucidate the costs and outcomes associated with treatments.


Clinical Insight Matters
We apply sophisticated techniques to mine, standardize, and aggregate health care data from disparate IT systems, all within a state-of-the-art, HIPAA-compliant, and highly secure environment. Humedica’s de-identified solutions provide:

  • Longitudinal clinical data needed to gain a more accurate picture of specific patient sub-populations;
  • Brand-specific clinical profiles, including lab and radiology results, for improved marketing message development and effectiveness tracking;
  • Clinical evidence for the development of refined segmentation strategies; and
  • Clinical data highlighting which treatments occurred when, and by which specialty, to accurately define the sequence of care and associated outcomes.


Humedica’s clinical data enable life sciences companies to:

  • Measure clinical outcomes within specific patient segments;
  • More accurately identify unmet needs and associated market opportunities; and
  • Tailor marketing messages to accurately address the specific needs of provider groups and patient cohorts.


With Humedica’s solutions, you will be able to quickly and accurately answer important business questions, such as the following:

  • Am I attracting the right patient segments based on my product’s unique clinical profile?
  • How does the clinical profile of patients on my brand compare to those of my competitors, both branded and generic?
  • In which patient segments does my brand outperform the competition in terms of clinical outcomes and cost effectiveness?
  • How do I maximize the pricing and reimbursement for my brand?


For more information on Humedica and our novel life science solutions, please contact us at lifesciences@humedica.com.